Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

1. Blauvelt, A.
2. Reich, K.
3. Tsai, T.-F.
4. Tyring, S.
5. Vanaclocha, F.
6. Kingo, K.
7. Ziv, M.
8. Pinter, A.
9. Vender, R.
10. Hugot, S.
11. You, R.
12. Milutinovic, M.
13. Thaçi, D.